Mitigative efficacy of the clinical dosage administration of granulocyte colony-stimulating factor and romiplostim in mice with severe acute radiation syndrome

BACKGROUND: It has been reported that the high-dosage administration of domestically approved pharmaceutical drugs, especially granulocyte colony-stimulating factor (G-CSF) and romiplostim (RP), is a rapid and appropriate medical treatment for preventing severe acute radiation syndrome (ARS) of vict...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Masaru, Suzuki, Marino, Funaba, Moeri, Chiba, Akane, Kashiwakura, Ikuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398212/
https://www.ncbi.nlm.nih.gov/pubmed/32746943
http://dx.doi.org/10.1186/s13287-020-01861-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398212/
https://www.ncbi.nlm.nih.gov/pubmed/32746943
http://dx.doi.org/10.1186/s13287-020-01861-x

Ejemplares similares